229 related articles for article (PubMed ID: 22520230)
1. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
[TBL] [Abstract][Full Text] [Related]
2. Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase.
Ohira M; Miyashita Y; Murano T; Watanabe F; Shirai K
Metabolism; 2009 Oct; 58(10):1408-14. PubMed ID: 19570550
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.
Saiki A; Murano T; Watanabe F; Oyama T; Miyashita Y; Shirai K
J Atheroscler Thromb; 2005; 12(3):163-8. PubMed ID: 16020917
[TBL] [Abstract][Full Text] [Related]
4. Induction of lipoprotein lipase gene expression in 3T3-L1 preadipocytes by atorvastatin, a cholesterol- and triglyceride-lowering drug.
Bey L; Maigret P; Laouenan H; Hamilton MT
Pharmacology; 2002 Sep; 66(1):51-6. PubMed ID: 12169766
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-lowering effect of pitavastatin in a guinea pig model of postprandial lipemia.
Aoki T; Yamazaki H; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2003; 53(3):154-8. PubMed ID: 12705169
[TBL] [Abstract][Full Text] [Related]
6. Role of AMPK and PPARγ1 in exercise-induced lipoprotein lipase in skeletal muscle.
Sasaki T; Nakata R; Inoue H; Shimizu M; Inoue J; Sato R
Am J Physiol Endocrinol Metab; 2014 May; 306(9):E1085-92. PubMed ID: 24644240
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins.
Morikawa S; Murakami T; Yamazaki H; Izumi A; Saito Y; Hamakubo T; Kodama T
J Atheroscler Thromb; 2005; 12(3):121-31. PubMed ID: 16020911
[TBL] [Abstract][Full Text] [Related]
8. Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes.
Ichida Y; Hasegawa G; Fukui M; Obayashi H; Ohta M; Fujinami A; Ohta K; Nakano K; Yoshikawa T; Nakamura N
Pharmacology; 2006; 76(1):34-9. PubMed ID: 16227702
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
Narumiya H; Sasaki S; Kuwahara N; Irie H; Kusaba T; Kameyama H; Tamagaki K; Hatta T; Takeda K; Matsubara H
Cardiovasc Res; 2004 Nov; 64(2):331-6. PubMed ID: 15485693
[TBL] [Abstract][Full Text] [Related]
10. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.
Ota K; Suehiro T; Arii K; Ikeda Y; Kumon Y; Osaki F; Hashimoto K
Metabolism; 2005 Feb; 54(2):142-50. PubMed ID: 15690306
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
[TBL] [Abstract][Full Text] [Related]
12. Effect of pitavastatin on sterol and bile acid excretion in guinea pigs.
Aoki T; Yamazaki H; Maejima T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2003; 53(5):351-6. PubMed ID: 12854362
[TBL] [Abstract][Full Text] [Related]
13. Statins activate AMP-activated protein kinase in vitro and in vivo.
Sun W; Lee TS; Zhu M; Gu C; Wang Y; Zhu Y; Shyy JY
Circulation; 2006 Dec; 114(24):2655-62. PubMed ID: 17116771
[TBL] [Abstract][Full Text] [Related]
14. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
Br J Pharmacol; 2007 Feb; 150(4):470-9. PubMed ID: 17220911
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells.
Ohkita M; Sugii M; Ka Y; Kitamura A; Mori T; Hayashi T; Takaoka M; Matsumura Y
Exp Biol Med (Maywood); 2006 Jun; 231(6):772-6. PubMed ID: 16740997
[TBL] [Abstract][Full Text] [Related]
17. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
[TBL] [Abstract][Full Text] [Related]
18. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
Maejima T; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
Biochem Biophys Res Commun; 2004 Nov; 324(2):835-9. PubMed ID: 15474503
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K
Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
